KureCells ISCT Top Scoring Abstract Award for UF-Kure19 Ph1 trial rkjamvi@gmail.com May 17, 2025 KureCells Share share .face-icon{fill:#fff;} .tw-icon{fill:#fff;} .ln-icon{fill:#fff;} .pn-icon{fill:#fff;}
KureCells UF-Kure19 granted RMAT designation by FDA based on promising efficacy for LBCL and follicular lymphoma and rapid manufacturing rkjamvi@gmail.com October 17, 2025
KureCells Kure Cells closed pre-Series A funding round led by Waed Ventures (Aramco) alongside NantBio, US93 and Qomel rkjamvi@gmail.com October 23, 2025
Leave a Reply